Synopsis: “On 20-21 October 2014, WHO convened a meeting of the Ethics Working Group to review ethical issues related to the study design for trials on therapeutic interventions related to Ebola virus disease and to provide advice on the ethical considerations that are relevant to each of the different study designs in a given context. Six case studies on the different trial designs for therapeutics were used to illustrate the ethical dimensions related to their implementation in the context of the Ebola epidemic. These allowed regulators, researchers, ethics committee chairs and administrators, and the representatives of pharmaceutical companies to discuss the advantages and disadvantages of the respective study designs and identify issues that were relevant for consideration in an ethical analysis during their conduct in an outbreak situation in the affected countries.”


Click here for :

Draft agenda

Participant list

Meeting summary




Tags: ,

Leave a Reply